- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Utility of SAM68 in the progression and prognosis for bladder cancer ; volume:15 ; number:1 ; day:6 ; month:5 ; year:2015 ; pages:1-8 ; date:12.2015
BMC cancer ; 15, Heft 1 (6.5.2015), 1-8, 12.2015
- Urheber
-
Zhang, Zhiling
- Beteiligte Personen und Organisationen
-
Yu, Chunping
Li, Yonghong
Jiang, Lijuan
Zhou, Fangjian
SpringerLink (Online service)
- DOI
-
10.1186/s12885-015-1367-x
- URN
-
urn:nbn:de:1111-2016110622183
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zhang, Zhiling
- Yu, Chunping
- Li, Yonghong
- Jiang, Lijuan
- Zhou, Fangjian
- SpringerLink (Online service)
Ähnliche Objekte (12)
GREM1 is a potential biomarker for the progression and prognosis of bladder cancer
MINDY1 promotes bladder cancer progression by stabilizing YAP
Decreased expression of RNA-binding motif protein 3 correlates with tumour progression and poor prognosis in urothelial bladder cancer
Predicting recurrence and progression in patients with non-muscle-invasive bladder cancer : utility of the EORTC and CUETO scoring models
Cancer derived exosomes induce macrophages immunosuppressive polarization to promote bladder cancer progression
Reduced membranous MET expression is linked to bladder cancer progression
Role of tyrosine kinases in bladder cancer progression: an overview
FOXM1 predicts disease progression in non-muscle invasive bladder cancer
Synthetic regulatory RNAs selectively suppress the progression of bladder cancer
The role of PAR1 in the progression of bladder cancer
Serum lactate dehydrogenase level predicts the prognosis in bladder cancer patients
Impact of urinary bladder cancer risk variants on prognosis and survival
GREM1 is a potential biomarker for the progression and prognosis of bladder cancer
MINDY1 promotes bladder cancer progression by stabilizing YAP
Decreased expression of RNA-binding motif protein 3 correlates with tumour progression and poor prognosis in urothelial bladder cancer
Predicting recurrence and progression in patients with non-muscle-invasive bladder cancer : utility of the EORTC and CUETO scoring models
Cancer derived exosomes induce macrophages immunosuppressive polarization to promote bladder cancer progression
Reduced membranous MET expression is linked to bladder cancer progression
Role of tyrosine kinases in bladder cancer progression: an overview
FOXM1 predicts disease progression in non-muscle invasive bladder cancer
Synthetic regulatory RNAs selectively suppress the progression of bladder cancer
The role of PAR1 in the progression of bladder cancer
Serum lactate dehydrogenase level predicts the prognosis in bladder cancer patients
Impact of urinary bladder cancer risk variants on prognosis and survival
GREM1 is a potential biomarker for the progression and prognosis of bladder cancer
MINDY1 promotes bladder cancer progression by stabilizing YAP
Decreased expression of RNA-binding motif protein 3 correlates with tumour progression and poor prognosis in urothelial bladder cancer
Predicting recurrence and progression in patients with non-muscle-invasive bladder cancer : utility of the EORTC and CUETO scoring models
Cancer derived exosomes induce macrophages immunosuppressive polarization to promote bladder cancer progression
Reduced membranous MET expression is linked to bladder cancer progression
Role of tyrosine kinases in bladder cancer progression: an overview
FOXM1 predicts disease progression in non-muscle invasive bladder cancer
Synthetic regulatory RNAs selectively suppress the progression of bladder cancer
The role of PAR1 in the progression of bladder cancer
Serum lactate dehydrogenase level predicts the prognosis in bladder cancer patients